- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
St. John's,NL
2013 FACE meeting
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Nausea/Vomiting
Motherisk Research
-
J Obstet Gynaecol. 2004 Aug;24(5):530-3.
Koren G, Maltepe C: Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum. -
Birth Defects Res A Clin Mol Teratol. 2004 Aug;70(8):528-30.
Boskovic R, Rudic N, Danieliewska-Nikiel B, Navioz Y, Koren G: Is lack of morning sickness teratogenic? A prospective controlled study. -
Am J Obstet Gynecol. 2003 Nov;189(5):1374-7.
Portnoi G et al: Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. -
J Psychosom Obstet Gynaecol 22: 7-12, 2001.
Mazzotta P, Stewart DE, Koren G, Magee LA: Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy. -
J Psychosom Obstet Gynaecol. 24: 71-5, 2003.
Chandra K, Magee L, Einarson A, Koren G: Nausea and vomiting in pregnancy: results of a survey that identified interventions used by women to alleviate their symptoms. -
J Obstet Gynaecol Can. 25: 830-3, 2003.
Boskovic R, Einarson A, Maltepe C, Wolpin J, Koren G: Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing. -
Crit Care Med. 2002 Aug;30(8):1883-92.
von Dadelszen P et al: Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? -
Am J Obstet Gynecol. 2002 May;185(5 Suppl Understanding):S256-61.
Magee LA, Mazzotta P, Koren G: Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). -
Am J Obstet Gynecol. 2002 May;185(5 Suppl Understanding):S248-52
Koren G, Levichek Z: The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk. -
Am J Obstet Gynecol. 2002 May;185(5 Suppl Understanding):S232-8.
Magee LA, Chandra K, Mazzotta P, Stewart D, Koren G, Guyatt GH: Development of a health-related quality of life instrument for nausea and vomiting of pregnancy. -
Am J Obstet Gynecol. 2002 May;185(5 Suppl Understanding):S228-31.
Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A: Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. -
J Clin Pharmacol 2001 Aug;41(8):842-5
Atanackovic G, Navioz Y, Moretti ME, Koren G: The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy. -
Ann Pharmacother. 2000 Dec;34(12):1486-7. No abstract available.
Einarson A, Levichek Z, Einarson TR, Koren G: The antiemetic effect of cetirizine during pregnancy. -
Eur J Obstet Gynecol Reprod Biol. 2001 Jan;94(1):31-36.
Koren G, Magee L, Attard C, Kohli M, Atanackovic G, Bishai R, Chandra K, Navioz Y, Maltepe C: A novel method for the evaluation of the severity of nausea and vomiting of pregnancy -
Can J Clin Pharmacol. 2000 Winter;7(4):205-8.
Lee J, Einarson A, Gallo M, Okotore B, Koren G: Longitudinal change in the treatment of nausea and vomiting of pregnancy in ontario. -
J Psychosom Obstet Gynaecol. 2000 Sep;21(3):129-36.
Mazzotta P, Stewart D, Atanackovic G, Koren G, Magee LA: Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy. -
Can J Clin Pharmacol. 2000 Autumn;7(3):138-43.
Bishai R, Mazzotta P, Atanackovic G, Levichek Z, Pole M, Magee LA, Koren G: Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6). -
Int J Gynaecol Obstet. 2000 Sep;70(3):359-65.
Mazzotta P, Maltepe C, Navioz Y, Magee LA, Koren G: Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada. -
Clin Invest Med. 1999 Jun;22(3):106-10
Emelianova S, Mazzotta P, Einarson A, Koren G: Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. -
Eur J Obstet Gynecol Reprod Biol. 1998 Jan;76(1):1-3. Review. No abstract available.
Einarson A, Koren G, Bergman U: Nausea and vomiting in pregnancy: a comparative European study. -
Reprod Toxicol 9: 1-6, 1995. No abstract available.
Ornstein M, Einarson A, Koren G: Bendectin/Diclectin for morning sickness; A Canadian follow-up of an American tragedy. -
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2146641/
Koren G: Drug of choice for morning sickness. Can Fam Physicians, 41: 1671-1674, 1995.












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)